Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 2 |
2009 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
J BUON. 2008 Oct-Dec;13(4):505-11.
J BUON. 2008.
PMID: 19145671
PATIENTS AND METHODS: Patients received LV5-FU2- oxaliplatin (oxaliplatin 85 mg/m(2), day 1; folinic acid 200 mg/m(2), days 1-2; 5-FU 400 mg/m(2), i.v. bolus, days 1-2; 5-FU 600 mg/m(2), 22-hour continuous infusion, days 1-2) or LV5- FU2-CDDP (CDDP 50 …
PATIENTS AND METHODS: Patients received LV5-FU2- oxaliplatin (oxaliplatin 85 mg/m(2), day 1; folinic acid 200 mg/m(2), days 1- …
Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone.
Tröger W, Jezdić S, Zdrale Z, Tišma N, Hamre HJ, Matijašević M.
Tröger W, et al.
Breast Cancer (Auckl). 2009 Jul 6;3:35-45. doi: 10.4137/bcbcr.s2905.
Breast Cancer (Auckl). 2009.
PMID: 21556248
Free PMC article.
PATIENTS AND METHODS: We conducted a prospective randomized open label pilot study with 95 patients randomized into three groups. Two groups received Iscador M special (IMS) or a different mistletoe preparation, respectively, additionally to chemotherapy with six cycles of …
PATIENTS AND METHODS: We conducted a prospective randomized open label pilot study with 95 patients randomized into three groups. Two groups …
Item in Clipboard
Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study.
Popov IP, Jelić SB, Krivokapić ZV, Jezdić SD, Pesko PM, Micev MT, Babić DR.
Popov IP, et al.
Med Oncol. 2008;25(1):73-80. doi: 10.1007/s12032-007-0042-8. Epub 2007 Nov 1.
Med Oncol. 2008.
PMID: 17972024
Clinical Trial.
PATIENTS AND METHODS: Histologically confirmed measurable advanced gastric cancer, age < 72 yr, ECOG performance status 0-2, no prior chemo- and radiotherapy, adequate organ functions. TREATMENT: EAP arm: doxorubicin (40 mg/m(2)), etoposide (360 mg/m(2)), and cis
…PATIENTS AND METHODS: Histologically confirmed measurable advanced gastric cancer, age < 72 yr, ECOG performance status 0-2, no prior che
…
Item in Clipboard
Cite
Cite